Inventor · disambiguated record
Christopher Bailey
Also filed as: BAILEY CHRISTOPHER · BAILEY CHRISTOPHER DAVID
6 granted patents·10 pending applications·11 citations·filing 2016–2024
75Inventor score
Files withPLIANT THERAPEUTICS INC8NOVARTIS AG2THERAVANCE BIOPHARMA R&D IP LLC2CHILDRENS NAT MEDICAL CT1CHILDRENS RES INSTITUTE CHILDRENS NATIONAL MEDICAL CENTER1
Top patents by PatentIndex Score
16 records- 0195US11560376B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2020·Granted Jan 24, 2023·6 cites·79 claims
- 0288US11858931B2Amino acid compounds with unbranched linkers and methods of usePLIANT THERAPEUTICS INC·Filed 2022·Granted Jan 2, 2024·1 cites·54 claims
- 0386US11952376B2Substituted amino acids as integrin inhibitorsPLIANT THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·1 cites·172 claims
- 0486US11396506B2Amino acid compounds with unbranched linkers and methods of usePLIANT THERAPEUTICS INC·Filed 2019·Granted Jul 26, 2022·3 cites·33 claims
- 0584US2025223288A1Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0677US2024270742A1Substituted amino acids as integrin inhibitorsPLIANT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0777US2024294520A1Amino acid compounds with unbranched linkers and methods of usePLIANT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0877US2023271960A1Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0971US2023399312A1Substituted pyrimidines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Application pending·0 cites
- 1065US11673879B2Substituted pyrimidines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Jun 13, 2023·0 cites·23 claims
- 1160US2021227865A1Low glycemic composition and methods of making and using thereofSEATTLE GUMMY COMPANY·Filed 2019·Application pending·0 cites
- 1258US2024139280A1Use of hif-1-alpha inhibitors in cancer immunotherapyONCOC4 INC·Filed 2022·Application pending·0 cites
- 1353US2024033317A1Uses of hypoxia-inducible factor inhibitors for treating tp53-mutated acute myeloid leukemiaCHILDRENS NAT MEDICAL CT·Filed 2021·Application pending·0 cites
- 1450US2023060422A1Combination treatment of liver diseases using integrin inhibitorsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1549US2023055657A1Combination treatment of liver diseases using integrin inhibitorsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1636US11116726B2Echinomycin formulation, method of making and method of use thereofCHILDRENS RES INSTITUTE CHILDRENS NATIONAL MEDICAL CENTER·Filed 2016·Granted Sep 14, 2021·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Bailey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →